Still hungry in week 2 of Mounjaro — what the evidence says

The myth: if Mounjaro is working, hunger disappears straight away

This is the most common misconception our prescribers hear. People expect the pen to arrive (in the plain DPD box, tracked to the door) and for appetite to drop within days. For a small number of people it does shift quickly, but that's the exception. The clinical reality is quieter and more gradual.

Tirzepatide works by activating two gut-hormone receptors, GIP and GLP-1, which together slow stomach emptying, signal fullness to the brain, and over time recalibrate appetite. But those signals build with the dose. The 2.5mg starter dose exists specifically to reduce the nausea and GI discomfort that higher doses can cause, it isn't the dose the trials used to demonstrate weight loss. Expecting full appetite suppression at 2.5mg is like expecting full engine power in first gear.

The NHS tirzepatide medicines page is clear that treatment is titrated gradually upward by the prescriber, and that the therapeutic benefit builds across that titration. If you're finding that week 2 on Mounjaro still feels hungry, you're well within the normal range for this stage of titration. Patience here isn't passive, it's the clinically correct response.

What the trial data actually shows about timing

In the SURMOUNT-1 trial, which enrolled thousands of adults with obesity and followed them for 72 weeks, the largest and most consistent drops in body weight came as doses progressed toward 10mg and 15mg. Average weight reduction at the highest dose reached around 20–21% over the full trial period. That result didn't arrive in week 2; it accumulated across a structured titration. You can read the detail in the SURMOUNT-1 paper in the New England Journal of Medicine.

What this means practically: the absence of hunger suppression in week 2 isn't a signal that the medicine won't work for you. It's a signal that you're at the beginning of the process, not the middle of it. Most people who go on to significant weight loss spent weeks 1 and 2 feeling much as you do now.

Some people do notice a mild reduction in appetite at 2.5mg, smaller portions feel sufficient, or they simply forget to snack. If that's happening for you, it's a positive sign of sensitivity to the medicine. If it isn't, that's also within the range of normal. Both are fine at this stage. For a closer look at how long after taking Mounjaro you can expect to stop feeling hungry, that page covers the timeline in more detail.

When to actually be concerned, and what to do

There are situations where persistent hunger is worth raising directly with your prescriber, not because something has gone wrong, but because clinical input can help.

If you reach 7.5mg or 10mg and hunger hasn't changed at all, that's a reasonable prompt for a conversation. It might indicate something about how you're responding to the medicine, or it might point to dietary or lifestyle factors worth reviewing alongside treatment. The Mounjaro not working and still hungry page covers those later-stage scenarios.

It's also worth checking the basics now: protein at each meal, adequate hydration, and not skipping food altogether (which can paradoxically worsen hunger signals for some people on GLP-1 medicines). These aren't substitutes for the medicine doing its job, they're the conditions that let it work best. Tirzepatide is licensed for use alongside a reduced-calorie diet and increased physical activity, not instead of lifestyle changes.

One thing to avoid: adjusting your dose yourself, or moving to a higher dose before your prescriber has reviewed your response. Titration timing exists for good reason, and if you want to understand how long Mounjaro takes to work across the full titration schedule, that page sets out the expected progression clearly. If you're keen to understand the schedule, what to expect in Mounjaro week 2 sets out the standard progression clearly. And if you're thinking about what the private treatment landscape looks like, including cost context, the weight-loss treatments overview is a useful place to start.

For most people at week 2, the right move is to stay the course, keep your prescriber updated, and let the dose do its work over the coming weeks. The week 3 hunger page picks up from here if you want to track what changes next. If anything feels wrong (severe stomach pain, signs of an allergic reaction, persistent vomiting) contact your prescriber or seek medical help promptly rather than waiting for your next review. Side effects can be reported via the MHRA Yellow Card scheme.

If you haven't yet started treatment and want a prescriber to review your full picture, you can start a free consultation with our clinical team today.